Presence & RecognitionEvent: September 8, 2026
Perspective Therapeutics presented most recent data from the VMT-α-NET study at ASCO 2026 with a data cutoff date of April 17, 2026.
Published
Signal category
Presence & Recognition
Quote
“Most recent data presented at ASCO 2026, with data cutoff date of April 17, 2026.”
— Perspective Therapeutics team
Company
Perspective Therapeutics
Game-changing therapies that make an impactful difference for cancer patients and the clinicians who treat them.
- Industry
- Pharmaceutical Manufacturing
- Company size
- 156 employees
We develop game-changing therapies that make an impactful difference for cancer patients and the clinicians who treat them.
Founded 2023